As Microsoft phases out older Exchange Server versions, IT leaders are facing new decisions about how to stay compliant and cost-efficient. Understanding the current licensing landscape for Windows ...

Demand for Apple’s Mac Mini has skyrocketed, particularly in China, as the small computer has become an ideal platform for experimenting with autonomous AI agents like OpenClaw and others. Now, a ...

Disclaimer: NerdWallet strives to keep its information accurate and up to date. This information may be different than what you see when you visit a financial institution, service provider or specific ...

As more drugmakers tally up their CEO compensation for 2025, yet another Big Pharma chief has collected above the $30 million threshold. Johnson & Johnson CEO Joaquin Duato has been awarded nearly $32 ...

Schools across the country have invested billions of dollars in tablets, laptops, and high-speed internet with the expectation that more technology means better learning. But what does the research ...

Azure SQL Managed Instance gains SQL Server 2025 update policy control. GA policy balances new engine features with operational stability governance. Enhanced update management supports enterprise ...

As we look ahead to another year of challenges in the farm economy, indicators of farm financial health are under close inspection. Filing for Chapter 12 bankruptcy is a last resort for farmers who ...

In May of 2025, MySQL celebrated its 30th anniversary. Not many technology projects go strong for three decades, let alone at the level of use that MySQL enjoys. MySQL is listed at #2 on the ...

Devart, a leading developer of database management software, is offering dbForge 2025.3, the latest update to its unified ecosystem of professional database tools—delivering expanded connectivity, ...

Johnson & Johnson had another strong quarter, driven by revenue growth of two important cancer drugs, but it also reported lower-than-expected net profit. J&J reported steady revenue performance in ...

Johnson & Johnson (JNJ), the earnings bellwether for the healthcare sector, reported better-than-expected revenue for Q4 2025 on Tuesday thanks to its Pharma and MedTech divisions. However, the shares ...